Joshua Drumm | Investor Relations. |
Travis Mickle | President and Chief Executive Officer |
LaDuane Clifton | Chief Financial Officer |
Daniel Busby | RBC Capital Markets |
Esther Rajavelu | Oppenheimer |
Good day, ladies and gentlemen, and welcome to the KemPharm's Third Quarter 2018 Corporate Update Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] As a reminder, this call is being recorded. I'd now like to turn the conference over to Josh Drumm of Investor Relations.